Ypsomed Holding AG, a healthcare company based in Switzerland, specializes in developing and manufacturing injection and infusion systems for self-administering medication. With a strong focus on diabetes and insulin injection, Ypsomed offers innovative products like pen needles with a unique click-on function. Operating in the healthcare industry, the company has a low risk ESG score of 15.7. Experience the convenience and reliability of Ypsomed's diabetes care and delivery systems goods and services.